• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医生对2型糖尿病患者胰岛素笔的认知与推荐

Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus.

作者信息

Peyrot Mark, Rubin Richard R

机构信息

Department of Sociology, Loyola College, Baltimore, MD 21210-2699, USA.

出版信息

Curr Med Res Opin. 2008 Aug;24(8):2413-22. doi: 10.1185/03007990802278644. Epub 2008 Jul 14.

DOI:10.1185/03007990802278644
PMID:18627641
Abstract

OBJECTIVE

To determine the way in which physicians perceive insulin pens and the factors that affect their recommendations and their patients' pen initiation/use.

RESEARCH DESIGN AND METHODS

Primary care physicians ( N = 300; 108 family practice, 192 internal medicine) and endocrinologists (N = 225) were recruited from national databases (IMS and AMA) to participate in an Internet survey. All data are self-reports. Measures include five dependent variables (the extent of suitability for patient segments, two pen-related behaviors--their frequency of presenting patients with the pen as a treatment option and strength of pen recommendation--and extent of their patients' pen initiation and use) and several potential correlates: practice characteristics; therapeutic philosophy and practices; perceptions of insulin pens (convenience, facilitation of self-care, blood glucose control efficacy, cost/coverage). Correlates of dependent variables were examined using multiple linear regression.

RESULTS

Significantly (p < 0.05) more patient pen use and/or successful pen initiation was reported by physicians who: (1) were more involved in clinical practice, were early adopters of clinical innovations or instructed their patients regarding insulin use; (2) reported less insulin mixing or therapeutic inertia; (3) perceived pens as efficacious and facilitating self-care; and (4) presented and recommended pens to their patients. More frequent presentation of pens to patients and/or stronger recommendation of pen use was reported by physicians who were early innovation adopters, reported less insulin mixing or therapeutic inertia, and perceived pens as convenient and efficacious (p < 0.05).

LIMITATIONS

The study is a cross-sectional survey using a self-administered questionnaire yielding unverified self-reports. Physicians treating few patients with diabetes mellitus or prescribing no insulin were excluded from the study.

CONCLUSIONS

Physicians' pen-related actions are a function of their personal and practice characteristics as well as their perceptions of pens. Physicians' presentation of pens as an option is strongly associated with perceived pen convenience, but physicians' pen recommendations and the estimated pen use/initiation of their patients are most strongly associated with the perception of clinically relevant pen attributes--glucose control efficacy and/or self-care facilitation.

摘要

目的

确定医生对胰岛素笔的认知方式以及影响他们推荐胰岛素笔和患者开始使用/使用胰岛素笔的因素。

研究设计与方法

从国家数据库(IMS和美国医学协会)招募基层医疗医生(N = 300;108名家庭医生,192名内科医生)和内分泌科医生(N = 225)参与一项网络调查。所有数据均为自我报告。测量指标包括五个因变量(对患者群体的适用程度、两种与笔相关的行为——向患者推荐笔作为治疗选择的频率和推荐笔的力度——以及患者开始使用和使用胰岛素笔的程度)和几个潜在的相关因素:执业特征;治疗理念和实践;对胰岛素笔的认知(便利性、促进自我护理、血糖控制效果、成本/保险范围)。使用多元线性回归分析因变量的相关因素。

结果

以下医生报告的患者使用胰岛素笔和/或成功开始使用胰岛素笔的情况显著更多(p < 0.05):(1)更多参与临床实践、是临床创新的早期采用者或指导患者使用胰岛素的医生;(2)报告胰岛素混合或治疗惰性较少的医生;(3)认为胰岛素笔有效且便于自我护理的医生;(4)向患者展示并推荐胰岛素笔的医生。早期采用创新、报告胰岛素混合或治疗惰性较少且认为胰岛素笔方便有效的医生报告向患者更频繁地展示胰岛素笔和/或更强力地推荐使用胰岛素笔(p < 0.05)。

局限性

该研究是一项横断面调查,使用自我填写的问卷,得到的是未经核实的自我报告。治疗糖尿病患者较少或未开具胰岛素处方的医生被排除在研究之外。

结论

医生与胰岛素笔相关的行为是其个人和执业特征以及对胰岛素笔认知的函数。医生将胰岛素笔作为一种选择展示与感知到的笔的便利性密切相关,但医生对胰岛素笔的推荐以及其患者预计的笔的使用/开始使用情况与对临床相关笔的属性——血糖控制效果和/或自我护理便利性的认知最密切相关。

相似文献

1
Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus.医生对2型糖尿病患者胰岛素笔的认知与推荐
Curr Med Res Opin. 2008 Aug;24(8):2413-22. doi: 10.1185/03007990802278644. Epub 2008 Jul 14.
2
Factors affecting use of insulin pens by patients with type 2 diabetes.影响2型糖尿病患者胰岛素笔使用的因素。
Diabetes Care. 2008 Mar;31(3):430-2. doi: 10.2337/dc07-1899. Epub 2007 Nov 26.
3
Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.医疗补助计划覆盖的2型糖尿病患者开始胰岛素笔治疗后的医疗费用及药物依从性:一项回顾性数据库分析
Clin Ther. 2007 Jun;29(6 Pt 1):1294-305. doi: 10.1016/j.clinthera.2007.07.007.
4
Factors associated with persistence and resumption of insulin pen use for patients with type 2 diabetes.与 2 型糖尿病患者继续使用胰岛素笔和重新使用胰岛素笔相关的因素。
Diabetes Technol Ther. 2011 Jan;13(1):43-8. doi: 10.1089/dia.2010.0128.
5
Reusable and disposable insulin pens for the treatment of diabetes: understanding the global differences in user preference and an evaluation of inpatient insulin pen use.可重复使用和一次性胰岛素笔治疗糖尿病:了解全球用户偏好差异,并评估住院患者胰岛素笔的使用情况。
Diabetes Technol Ther. 2010 Jun;12 Suppl 1:S79-85. doi: 10.1089/dia.2009.0179.
6
Patient perceptions of insulin detemir as reported through patient telephone surveys.
Curr Med Res Opin. 2007 Sep;23(9):2043-9. doi: 10.1185/030079907X219508.
7
Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.胰岛素处方障碍研究(SHIP):一种新型自填式问卷的开发、评分及初步验证
Health Qual Life Outcomes. 2007 Aug 29;5:53. doi: 10.1186/1477-7525-5-53.
8
[Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].[2型糖尿病患者的降糖药物及耗材成本与治疗满意度。医疗保健研究LIVE-DE(德国甘精胰岛素与中性鱼精蛋白锌胰岛素对比)研究结果]
Dtsch Med Wochenschr. 2009 Jun;134(23):1207-13. doi: 10.1055/s-0029-1222595. Epub 2009 May 26.
9
Physician gender is associated with the quality of type 2 diabetes care.医生性别与2型糖尿病护理质量相关。
J Intern Med. 2008 Oct;264(4):340-50. doi: 10.1111/j.1365-2796.2008.01967.x. Epub 2008 Apr 4.
10
Functionality and acceptability of a new electronic insulin injection pen with a memory feature.一种具有记忆功能的新型电子胰岛素注射笔的功能与可接受性。
Curr Med Res Opin. 2006 Feb;22(2):315-25. doi: 10.1185/030079906X80477.

引用本文的文献

1
Vial-to-Pen: Community-Based Pharmacists Converting Insulin Regimens.从药瓶到胰岛素笔:社区药剂师转换胰岛素治疗方案
Innov Pharm. 2019 Jul 8;10(3). doi: 10.24926/iip.v10i3.939. eCollection 2019.
2
Using Cluster Analysis to Understand Clinician Readiness to Promote Continuous Glucose Monitoring Adoption.运用聚类分析来了解临床医生对推广持续血糖监测应用的准备情况。
J Diabetes Sci Technol. 2018 Nov;12(6):1108-1115. doi: 10.1177/1932296818786486. Epub 2018 Jul 11.
3
A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies.
一项针对美国启动注射治疗的2型糖尿病管理式医疗患者治疗模式和结局的真实世界研究。
Diabetes Obes Metab. 2017 Mar;19(3):375-386. doi: 10.1111/dom.12828. Epub 2017 Jan 20.
4
Development and validation of the Diabetes Medication System Rating Questionnaire-Short Form.糖尿病药物治疗系统评分问卷简表的开发与验证
Diabet Med. 2014 Oct;31(10):1237-44. doi: 10.1111/dme.12453. Epub 2014 Apr 18.
5
Review of insulin therapy and pen use in hospitalized patients.住院患者胰岛素治疗及胰岛素笔使用情况综述
Hosp Pharm. 2013 May;48(5):396-405. doi: 10.1310/hpj4805-396.
6
The INITIATOR study: pilot data on real-world clinical and economic outcomes in US patients with type 2 diabetes initiating injectable therapy.启动者研究:美国2型糖尿病患者开始注射治疗的真实世界临床和经济结局的试点数据。
Adv Ther. 2013 Dec;30(12):1128-40. doi: 10.1007/s12325-013-0074-8. Epub 2013 Nov 30.
7
Perceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients' cognitive framework.2型糖尿病患者对药物益处的认知及其与使用吸入性胰岛素意愿的关联:患者认知框架模型
Patient Prefer Adherence. 2011;5:255-65. doi: 10.2147/PPA.S18799. Epub 2011 Jun 7.
8
Should A1C targets be individualized for all people with diabetes? Arguments for and against.糖化血红蛋白(A1C)目标是否应为所有糖尿病患者个体化设定?支持与反对的观点。
Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S191-6. doi: 10.2337/dc11-s217.